Salusin-αSalusin-α - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-P10616.804-HY-P10616804-HY-P10616Business & Industrial > Science & LaboratorySalusin-α
Gentaur
EUR12027-02-23

Salusin-α

CAT:
804-HY-P10616
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Salusin-α - image 1

Salusin-α

  • Description:

    Salusin-α is an endogenous bioactive peptide with hemodynamic and cell proliferation activities. Salusin-α can stimulate the proliferation of quiescent vascular smooth muscle cells (VSMCs) and fibroblasts, leading to a rapid and significant decrease in blood pressure and heart rate, but its effect is weaker than that of Salusin-β (HY-P10617) . Salusin-α has potential application value in cardiovascular disease research[1].
  • UNSPSC:

    12352209
  • Target:

    Endogenous Metabolite
  • Type:

    Peptides
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/salusin-α.html
  • Smiles:

    O=C(N1[C@@H](CCC1)C(N[C@@H](C)C(N2[C@@H](CCC2)C(N[C@@H](C)C(N[C@@H](C)C(N3[C@@H](CCC3)C(N[C@@H](CCCNC(N)=N)C(N4[C@@H](CCC4)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(NCC(N5[C@@H](CCC5)C(N[C@@H](C)C(NCC(N6[C@@H](CCC6)C(NCC(N[C@@H](C)C(N[C@H](C(N)=O)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]7N(CCC7)C([C@H](CC(C)C)NC([C@H](C)NC(CNC([C@@H](N)CO)=O)=O)=O)=O
  • Molecular Formula:

    C114H192N40O30
  • Molecular Weight:

    2602.99
  • References & Citations:

    [1]Shichiri, et al. "Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities." Nature medicine 9.9 (2003) : 1166-1172.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [624735-22-4]